A Program To Accelerate Sales
AbbVie seeks EMA marketing authorisation for preventive migraine therapy
The MAA is based on data from two Phase III trials of atogepant in adult patients with episodic and chronic migraine.
Ascletis seeks marketing authorisation for ritonavir in eight European countries
EC grants marketing authorisation for Pfizer-OPKO’s Ngenla injection
Molnupiravir Q4 forecast sales grow by 17,500% compared to Q3 forecast
EC grants marketing authorisation to GSK-Vir’s Xevudy for Covid-19
Acute glass bottle shortage threatens US spirits sales – leading macroeconomic influencers
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
